Dipeptidyl peptidase-4 inhibitors and the risk of infection: A systematic review and meta-analysis of cardiovascular outcome trials
Article in World Journal of Diabetes (May 2024)
The most recent citing publications are shown below. View all 27 publications that cite this research output on Dimensions.
Comparison of Efficacy of Dipeptidyl Peptidase‐4 Inhibitors and Sodium‐Glucose Co‐Transporter 2 Inhibitors Between Japanese and Non‐Japanese Patients: A Meta‐Analysis
Article in Clinical and Translational Science (January 2020)
Benefit-Risk Assessment of Alogliptin for the Treatment of Type 2 Diabetes Mellitus
Article in Drug Safety (October 2019)